|
Groundbreaking Public-Private Collaboration Combines Personalized Medicine and Novel Trial Design to Develop Potentially Life Saving New Breast Cancer Drugs |
|
|
|
Today, March 17, 2010, leaders from the academic research community, members of congress, including Senator Arlen Specter (D-PA), and leaders from government agencies, including Dr. Janet Woodcock from The Food and Drug Administration (FDA) and Anna Barker from The National Cancer Institute (NCI), joined
|
|
Read more...
|
|
|
|
<< Start < Prev 1 2 Next > End >>
|
|
Page 1 of 2 |